These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8695640)

  • 1. Characterization of site I on human serum albumin: concept about the structure of a drug binding site.
    Yamasaki K; Maruyama T; Kragh-Hansen U; Otagiri M
    Biochim Biophys Acta; 1996 Jul; 1295(2):147-57. PubMed ID: 8695640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin.
    Sakai T; Yamasaki K; Sako T; Kragh-Hansen U; Suenaga A; Otagiri M
    Pharm Res; 2001 Apr; 18(4):520-4. PubMed ID: 11451040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin.
    Yamasaki K; Hyodo S; Taguchi K; Nishi K; Yamaotsu N; Hirono S; Chuang VTG; Seo H; Maruyama T; Otagiri M
    PLoS One; 2017; 12(6):e0180404. PubMed ID: 28662200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition.
    Yamasaki K; Maruyama T; Yoshimoto K; Tsutsumi Y; Narazaki R; Fukuhara A; Kragh-Hansen U; Otagiri M
    Biochim Biophys Acta; 1999 Jul; 1432(2):313-23. PubMed ID: 10407153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug binding sites on chicken albumin: a comparison to human albumin.
    Rajaian H; Symonds HW; Bowmer CJ
    J Vet Pharmacol Ther; 1997 Dec; 20(6):421-6. PubMed ID: 9430764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of site I of human serum albumin using spectroscopic analyses: locational relations between regions Ib and Ic of site I.
    Yamasaki K; Maruyama T; Takadate A; Suenaga A; Kragh-Hansen U; Otagiri M
    J Pharm Sci; 2004 Dec; 93(12):3004-12. PubMed ID: 15468330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of coumarins to site I of human serum albumin. Effect of the fatty acids.
    Zatón AM; Ferrer JM; Ruiz de Gordoa JC; Marquínez MA
    Chem Biol Interact; 1995 Jul; 97(2):169-74. PubMed ID: 7606814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of binding site of uremic toxins on human serum albumin.
    Sakai T; Takadate A; Otagiri M
    Biol Pharm Bull; 1995 Dec; 18(12):1755-61. PubMed ID: 8787801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase.
    Noctor TA; Wainer IW; Hage DS
    J Chromatogr; 1992 Jun; 577(2):305-15. PubMed ID: 1400761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism.
    Okabe N; Hashizume N
    Biol Pharm Bull; 1994 Jan; 17(1):16-21. PubMed ID: 8148809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.
    Tillement JP; Zini R; d' Athis P; Vassent G
    Eur J Clin Pharmacol; 1974 Jul; 7(4):307-13. PubMed ID: 4850753
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
    Panjehshahin MR; Bowmer CJ; Yates MS
    Biochem Pharmacol; 1991 Apr; 41(8):1227-33. PubMed ID: 1706921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding sites of fluorescent probes on human serum albumin.
    Muller N; Lapicque F; Drelon E; Netter P
    J Pharm Pharmacol; 1994 Apr; 46(4):300-4. PubMed ID: 7519671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the aflatoxin B1-binding site of rat albumin.
    Dirr HW; Schabort JC
    Biochim Biophys Acta; 1987 Jul; 913(3):300-7. PubMed ID: 3109487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid.
    Hervé F; Rajkowski K; Martin MT; Dessen P; Cittanova N
    Biochem J; 1984 Jul; 221(2):401-6. PubMed ID: 6206846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of sulindac competition with specific markers for the major binding sites on human serum albumin.
    Russeva VN; Zhivkova ZD
    Arzneimittelforschung; 2003; 53(3):174-81. PubMed ID: 12705172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The investigation of the binding of 6-mercaptopurine to site I on human serum albumin.
    Sochacka J; Baran W
    Protein J; 2012 Dec; 31(8):689-702. PubMed ID: 23001616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fluorescent reporter detects details of aromatic ligand interference in drug-binding sites of human serum albumin.
    Dobretsov G; Smolina N; Syrejshchikova T; Brilliantova V; Uzbekov M
    Biochem Biophys Res Commun; 2016 Sep; 478(1):462-466. PubMed ID: 27318089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.